Clinical Trial Update: A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease

View source ↗

Summary

A completed study comparing the safety and tolerability of two doses of fipamezole in adults with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Fipamezole

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Parkinson's Disease | Status: COMPLETED